Work in progress report - Experimental gene therapy during cardiac surgery: Role of surgical technique to minimize collateral organ gene expression

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 6, 2010, Pages 727-731

  Katz, Michael G ^a   Swain, JaBaris D ^a   Fargnoli, Anthony S ^a   Bridges, Charles R ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Adeno associated virus; Cardiac gene therapy; Cardiac surgery; Green fluorescent protein; Organ gene expression

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CLINICAL EFFECTIVENESS; COLLATERAL CIRCULATION; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; GENE THERAPY; HEART SURGERY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SHEEP; SURGICAL TECHNIQUE; VIRAL GENE DELIVERY SYSTEM; ADENO ASSOCIATED VIRUS; ANIMAL; BIOSYNTHESIS; CARDIOPULMONARY BYPASS; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEART FAILURE; PATHOPHYSIOLOGY; PEROPERATIVE CARE; POLYMERASE CHAIN REACTION; TIME;

ANIMALS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; COLLATERAL CIRCULATION; CYTOMEGALOVIRUS; DEPENDOVIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEART FAILURE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE CARE; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SHEEP; TIME FACTORS;

EID: 78649585310     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.244301     Document Type: Article

References (15)

1. Katz MG, Swain JB, White JD, Low D, Stedman H, Bridges CR. Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum Gene Ther 2010;21:371-380.
2. Bridges CR, Gopal K, Holt DE, Yarnall C, Cole S, Anderson RB, Yin X, Nelson A, Kozyak BW, Wang Z, Lesniewski J, Su LT, Thesier DM, Sundar H, Stedman HH. Efficient myocyte gene delivery with complete cardiac surgical isolation in situ. J Thorac Cardiovasc Surg 2005;130:1364-1370.
3. Jones JM, Wilson KH, Koch WJ, Milano CA. Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression. Eur J Cardiothorac Surg 2002; 21:847-852.
4. Davidson MJ, Jones JM, Emani SM, Wilson KH, Jaggers J, Koch WJ, Milano CA. Cardiac gene delivery with cardiopulmonary bypass. Circulation 2001;104:131-133.
5. Zolotuchin S, Byrne BJ, Mason E, Zolotuchin I, Potter M, Chestnut K, Summerford C, Samulski RJ, Muzyczka N. Recombinant adeno-associ-ated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999;6:973-985.
6. Bridges CR, Burkman JM, Malekan R, Konig SM, Chen H, Yarnall CB, Gardner TJ, Stewart AS, Stecker MM, Patterson T, Stedman HH. Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg 2002;73:1939-1946.
7. Boekstegers P, von Degenfeld G, Giehrl W, Heinrich D, Hullin R, Kupatt C, Steinbeck G, Baretton G, Middeler G, Katus H, Franz WM. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 2000;7:232-240.
8. Parlington MT, Acar C, Buckberg GD, Kofsky ER, Bugyi HI. Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied open and occluded arteries. J Thorac Cardiovasc Surg 1989;97:605-612.
9. Besoluk K, Tipirdamaz S. Comparative macroanatomic investigations of the venous drainage of the heart in Akkaraman sheep and Angora goats. Anat Histol Embryol 2001;30:249-252.
10. Ansari A. Anatomy and clinical significance of ventricular thebesian veins. Clin Anat 2001;14:102.
11. Rudis E, Gates RN, Laks H, Drinkwater DC, Ardehali A, Aharon A, Chang P. Coronary sinus ostial occlusion during retrograde delivery of cardi-oplegic solution significantly improves cardioplegic distribution and efficacy. J Thorac Cardiovasc Surg 1995;109:941-947.
12. Tosson R, Kuschkowitz F, Dasbach G, Lacskovics A. Relationship between of the coronary sinus catheter and distribution of cardioplegia. J Heart Valve Dis 1999;8:120-123.
13. Hammond GL, Davies AL, Austen WG. Retrograde coronary sinus perfu-sion: a method of myocardial protection in dog during left coronary artery occlusion. Ann Surg 1967;166:39-50.
14. Eke CC, Gundry SR, Fukushima N, Bailey LL. Is there a safe limit to coronary sinus pressure during retrograde cardioplegia? Am Surg 1997;63:417-420.
15. Mohl W, Kajgana I, Bergmeister H, Rattay F. Intermittent pressure elevation of coronary venous system as a method to protect ischemic myocardium. Interact CardioVasc Thorac Surg 2005;4:66-69.